Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gisli Jenkins

Showing results (161-170 of 208) with videos related to

Pageof 21
Sort By:
Communications Biology|March 24, 2021
Identification of a missense variant in SPDL1 associated with idiopathic pulmonary fibrosisRyan S Dhindsa, Johan Mattsson, Abhishek Nag, et al.
European Journal of Pharmacology|November 11, 2021
Pharmacological characterisation of GSK3335103, an oral αvβ6 integrin small molecule RGD-mimetic inhibitor for the treatment of fibrotic diseaseAlex L Wilkinson, Alison E John, John W Barrett, et al.
BMJ Open Respiratory Research|April 9, 2026
Association of bronchoalveolar lavage cellular analysis and radiological findings in fibrotic interstitial lung diseasesPunchalee Kaenmuang, Joseph L Barnett, Toby M Maher, et al.
The Lancet. Respiratory Medicine|May 1, 2025
Rare variants and survival of patients with idiopathic pulmonary fibrosis: analysis of a multicentre, observational cohort study with independent validationAitana Alonso-González, David Jáspez, José M Lorenzo-Salazar, et al.
Medrxiv : the Preprint Server for Health Sciences|November 1, 2024
Rare variants and survival of patients with idiopathic pulmonary fibrosisAitana Alonso-Gonzalez, David Jáspez, José M Lorenzo-Salazar, et al.
Plos Pathogens|August 10, 2016
An Epithelial Integrin Regulates the Amplitude of Protective Lung Interferon Responses against Multiple Respiratory PathogensVictoria A Meliopoulos, Lee-Ann Van de Velde, Nicholas C Van de Velde, et al.
American Journal of Respiratory and Critical Care Medicine|June 15, 2016
Acute Exacerbation of Idiopathic Pulmonary Fibrosis. An International Working Group ReportHarold R Collard, Christopher J Ryerson, Tamera J Corte, et al.
JAMA|May 9, 2023
Ziritaxestat, a Novel Autotaxin Inhibitor, and Lung Function in Idiopathic Pulmonary Fibrosis: The ISABELA 1 and 2 Randomized Clinical TrialsToby M Maher, Paul Ford, Kevin K Brown, et al.
International Journal of Cancer|January 18, 2019
β<sub>6</sub> -integrin serves as a novel serum tumor marker for colorectal carcinomaSusan Bengs, Eugenia Becker, Philipp Busenhart, et al.
The European Respiratory Journal|October 22, 2021
Biomarker signatures for progressive idiopathic pulmonary fibrosisBritt Clynick, Tamera J Corte, Helen E Jo, et al.
Pageof 21

Showing results (161-170 of 208) with videos related to

Sort By:
Pageof 21
Communications Biology|March 24, 2021
Identification of a missense variant in SPDL1 associated with idiopathic pulmonary fibrosisRyan S Dhindsa, Johan Mattsson, Abhishek Nag, et al.
European Journal of Pharmacology|November 11, 2021
Pharmacological characterisation of GSK3335103, an oral αvβ6 integrin small molecule RGD-mimetic inhibitor for the treatment of fibrotic diseaseAlex L Wilkinson, Alison E John, John W Barrett, et al.
BMJ Open Respiratory Research|April 9, 2026
Association of bronchoalveolar lavage cellular analysis and radiological findings in fibrotic interstitial lung diseasesPunchalee Kaenmuang, Joseph L Barnett, Toby M Maher, et al.
The Lancet. Respiratory Medicine|May 1, 2025
Rare variants and survival of patients with idiopathic pulmonary fibrosis: analysis of a multicentre, observational cohort study with independent validationAitana Alonso-González, David Jáspez, José M Lorenzo-Salazar, et al.
Medrxiv : the Preprint Server for Health Sciences|November 1, 2024
Rare variants and survival of patients with idiopathic pulmonary fibrosisAitana Alonso-Gonzalez, David Jáspez, José M Lorenzo-Salazar, et al.
Plos Pathogens|August 10, 2016
An Epithelial Integrin Regulates the Amplitude of Protective Lung Interferon Responses against Multiple Respiratory PathogensVictoria A Meliopoulos, Lee-Ann Van de Velde, Nicholas C Van de Velde, et al.
American Journal of Respiratory and Critical Care Medicine|June 15, 2016
Acute Exacerbation of Idiopathic Pulmonary Fibrosis. An International Working Group ReportHarold R Collard, Christopher J Ryerson, Tamera J Corte, et al.
JAMA|May 9, 2023
Ziritaxestat, a Novel Autotaxin Inhibitor, and Lung Function in Idiopathic Pulmonary Fibrosis: The ISABELA 1 and 2 Randomized Clinical TrialsToby M Maher, Paul Ford, Kevin K Brown, et al.
International Journal of Cancer|January 18, 2019
β<sub>6</sub> -integrin serves as a novel serum tumor marker for colorectal carcinomaSusan Bengs, Eugenia Becker, Philipp Busenhart, et al.
The European Respiratory Journal|October 22, 2021
Biomarker signatures for progressive idiopathic pulmonary fibrosisBritt Clynick, Tamera J Corte, Helen E Jo, et al.
Pageof 21